Ignite Creation Date:
2024-05-06 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05339087
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2022-04-14
Brief Title:
Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH
Sponsor:
Heidelberg University
Organization:
Heidelberg University
Organization Data
Organization:
Heidelberg University
Class:
OTHER
Study ID:
2020-01RCT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Heidelberg University
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Dr med Ekkehard Gruenig
Responsible Party Title:
Head of section for pulmonary hypertension Thoraxklinik Heidelberg gGmbH
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Heidelberg University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |